EFFECT OF CYTOKINES IN HOST DEFENSE AND INFLAMMATION
EFFECT OF CYTOKINES IN HOST DEFENSE AND INFLAMMATION
批准号:
3746562
负责人:
J I GALLIN
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Actinomycetales infection adolescence (12-20) blister child (0-11) chronic granulomatous disease colony stimulating factor cytokine endotoxins human subject hyperglobulinemia immunotherapy inflammation interferon gamma interleukin 1 interleukin 6 interleukin 8 microorganism immunology neutrophil tumor necrosis factor alpha
中文摘要
进行研究以确定细胞因子和其他细胞因子的积累。
实验性炎症模型中的炎症介质
正常人受试者和宿主防御异常的患者
或炎症。 通过抽吸和加热产生的皮肤水泡用于
研究皮肤的局部炎症。 出现的动力学
水疱液中的炎性细胞因子显示介质出现
早期(C5 a,LTB 4,IL-1 β和IL-8)和介质出现晚于12
小时或更晚(TNF-α和GM-CSF),未检测到IL-1 α和IL-2。
异常炎症反应患者皮肤水疱的研究
在急性胰腺炎患者中,
与韦格纳肉芽肿病相关的血管炎,
系统性肥大细胞增多症,以及高免疫球蛋白E综合征,
反复感染。 TNF-α的增加与
疾病活动表明,针对
这种细胞因子的调节在这些疾病中具有特殊的优点
states. 正常水疱渗出液中性粒细胞合成大量的
与对照外周血相比,IL-6、IL-8和TNF-α
中性粒细胞 正常人和过度炎症患者的研究
IL-8水平与血清IL-10水平呈线性关系。
渗出液中炎性中性粒细胞的数量。 中性粒细胞渗出液
合成IL-8,其储存在不同于特定
或嗜天青颗粒,但与富含碱性磷酸酶的
质膜分数 E.大肠杆菌内毒素
志愿者和患者根据长期的NIAID
议定书 TNF-α、TNF-α受体、IL-10、IL-11、IL-12、IL-13、IL-14、IL-18、IL-19、IL
1 α受体拮抗剂、IL-6和IL-8在4 h内出现,G-CSF
6 h时增加,但IL-1 α、IL-1 β、IL-2、IL-3、IL-10、IL-11、IL-12、IL-13、IL-14、IL-15、IL-16、IL-18、IL-19、IL
4、IL-10、干扰素-γ、TGF-β或C5 a。有一个
内毒素后2-4小时循环E-选择素显著增加
这是剂量相关的,表明E-选择素可能是
预测那些患有内毒素血症的患者将进展为休克。
不同疾病中异常的特定介质的定义
国家对开发治疗方法很重要。 在其他研究中,
慢性肉芽肿性疾病患者的长期监测
正在接受干扰素γ作为感染预防的儿童
表明无不良反应。 在其他研究中,
显示出在增强宿主抵抗感染中是有用的
包括MAI的分枝杆菌。
英文摘要
Studies were performed to define the accumulation of cytokines and other
mediators of inflammation in experimental models of inflammation in
normal human subjects and in patients with abnormalities of host defenses
or inflammation. Skin blisters created by suction and heat were used to
study local inflammation in the skin. The kinetics of the appearance of
inflammatory cytokines in the blister fluid revealed mediators appearing
early (C5a, LTB4, IL1beta, and IL-8) and mediators appearing late at 12
hrs or later (TNF-alpha and GM-CSF) with IL-1alpha and IL-2 not detected.
Studies of skin blisters in patients with abnormal inflammatory responses
revealed dramatic increases in TNF-alpha in patients with acute
vasculitis in association with Wegeners granulomatosis, in patients with
systemic mastocytosis, and in the syndrome of hyperimmunoglobulin E and
recurrent infections. Increases in TNF-alpha correlated well with
disease activity suggesting that targeting drug development for
modulation of this cytokine will have specific merit in these disease
states. Normal blister exudate neutrophils synthesize large amounts of
IL-6, IL-8, and TNF-alpha compared with control peripheral blood
neutrophils. Studies of normals and patients with excessive inflammation
revealed a tight linear relationship between the level of IL-8 and the
number of inflammatory neutrophils in the exudate. Exudate neutrophils
synthesize IL-8 which is stored in a compartment different from specific
or azurophil granules, but is co-eluted with an alkaline phosphatase rich
plasma membrane fraction. E. coli endotoxin was administered to normal
volunteers and patients in accordance with a long standing NIAID
protocol. Increased plasma levels of TNF-alpha, TNF-alpha receptor, IL-
1alpha receptor antagonist, IL-6 and IL-8 occurred within 4h and G-CSF
increased by 6 h, but not changes in IL-1alpha, IL-1beta, IL-2, IL-3, IL-
4, IL-10, interferon-gamma, TGF-beta or C5a were seen. There was a
striking increase in circulating E-selectin by 2-4 h after endotoxin
administration which was dose related suggesting that E-selectin may be
predictive of those patients with endotoxemia who will progress to shock.
Definition of specific mediators that are abnormal in different disease
states is important for developing therapies. In other studies the long
term monitoring of patients with chronic granulomatous disease of
childhood who are receiving interferon gamma as infectious prophylaxis
indicated no adverse effects. In other studies interferon-gamma was
shown to be useful in enhancing host defense against infection with
mycobacteria including MAI.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EFFECT OF CYTOKINES IN HOST DEFENSE AND INFLAMMATION
-
批准号:5200490
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J I GALLIN
-
依托单位:
EFFECT OF CYTOKINES IN HOST DEFENSE AND INFLAMMATION
-
批准号:3803217
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J I GALLIN
-
依托单位:
NEUTROPHIL SUBPOPULATIONS
-
批准号:3822020
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J I GALLIN
-
依托单位:
CLINICAL STUDIES OF ABNORMAL HOST DEFENSE
-
批准号:2566706
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J I GALLIN
-
依托单位:
PHAGOCYTIC CELL FUNCTION
-
批准号:3809559
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J I GALLIN
-
依托单位:
CLINICAL STUDIES OF ABNORMAL HOST DEFENSE
-
批准号:3803099
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J I GALLIN
-
依托单位:
PHAGOCYTIC CELL FUNCTION
-
批准号:3821970
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J I GALLIN
-
依托单位:
CLINICAL STUDIES OF ABNORMAL HOST DEFENSE
-
批准号:6160549
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J I GALLIN
-
依托单位:
CLINICAL STUDIES OF ABNORMAL HOST DEFENSE
-
批准号:5200399
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J I GALLIN
-
依托单位:
PHAGOCYTIC CELL FUNCTION
-
批准号:3818118
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J I GALLIN
-
依托单位:
PHAGOCYTIC CELL FUNCTION
-
批准号:3960456
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J I GALLIN
-
依托单位:
PHAGOCYTIC CELL FUNCTION
-
批准号:4688371
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J I GALLIN
-
依托单位:
EFFECT OF CYTOKINES IN HOST DEFENSE AND INFLAMMATION
-
批准号:3768819
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J I GALLIN
-
依托单位:
CLINICAL STUDIES OF ABNORMAL HOST DEFENSE
-
批准号:3746465
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J I GALLIN
-
依托单位:
EFFECT OF CYTOKINES IN HOST DEFENSE AND INFLAMMATION
-
批准号:3818290
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J I GALLIN
-
依托单位:
NEUTROPHIL SUBPOPULATIONS
-
批准号:3960512
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J I GALLIN
-
依托单位:
EFFECT OF CYTOKINES IN HOST DEFENSE AND INFLAMMATION
-
批准号:6160628
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J I GALLIN
-
依托单位:
EFFECT OF CYTOKINES IN HOST DEFENSE AND INFLAMMATION
-
批准号:3809692
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J I GALLIN
-
依托单位:
CLINICAL STUDIES OF ABNORMAL HOST DEFENSE
-
批准号:3768735
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J I GALLIN
-
依托单位:
CLINICAL STUDIES OF ABNORMAL HOST DEFENSE
-
批准号:3790672
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J I GALLIN
-
依托单位: